RenaissanceRe Holdings Ltd. filings document the regulatory record for a Bermuda-based reinsurance and insurance company with NYSE-listed common shares and depositary shares representing interests in Series F and Series G preference shares. Recent Form 8-K reports furnish financial-result releases and supplements covering underwriting performance, fee income and net investment income.
The company's proxy and governance filings cover shareholder voting, director matters, executive compensation and equity-based incentive plan approvals. Material-event filings also document capital-structure and financing arrangements, including secured letter of credit facilities involving RenaissanceRe reinsurance subsidiaries, alongside recurring disclosures on registered securities and corporate governance actions.
RenaissanceRe Holdings executive vice president and chief portfolio officer Curtis Ross reported open-market sales of 20,000 shares of company common stock on February 4–5, 2026.
The shares were sold in four 5,000-share blocks at prices of $290, $295, $300 and $305 per share under a Rule 10b5-1 trading plan adopted on November 24, 2024. After these transactions, Ross beneficially owns 166,813 shares of RenaissanceRe common stock directly.
RenaissanceRe Holdings Ltd filed a notice that a shareholder plans to sell 5,000 shares of common stock under Rule 144. The proposed sale, through Merrill Lynch on the NYSE, has an aggregate market value of $1,528,756.81, with 46,109,518 shares outstanding.
The shares include stock acquired via vesting of restricted stock unit awards on March 1 and March 18, 2024, totaling 2,242 and 2,758 shares, granted under the issuer’s equity compensation plan. The filer represents not knowing any undisclosed material adverse information about the company’s current or prospective operations.
Ross Curtis has filed a Form 144 notice to sell 5,000 shares of common stock through Merrill Lynch on the NYSE, with an aggregate market value of 1,525,000 and an approximate sale date of 02/05/2026.
The shares were originally acquired from the issuer as stock bonuses on 11/10/2015 (1,200 shares) and 12/30/2015 (3,800 shares), with cash payment on those dates. During the past three months, Ross Curtis also sold 15,000 common shares on 02/04/2026 for gross proceeds of 4,425,000.
RNR filed a Form 144/A notice for a planned sale of common stock. The person for whose account the securities are to be sold plans to sell 15,000 common shares through Merrill Lynch on the NYSE, with an aggregate market value of $4,425,000 and 43,961,539 shares outstanding. The shares were originally acquired from the issuer as stock bonuses in several transactions between 2014 and 2015, paid for in cash. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
A shareholder of RNR has filed a notice of proposed sale of 15,000 shares of common stock through broker Merrill Lynch on the NYSE, with an indicated aggregate market value of 4,425,000. The filing lists 127,694 shares outstanding for this class.
The shares to be sold were originally acquired from the issuer as stock bonuses on 03/01/2014, 03/01/2015, and 11/10/2015, in amounts of 8,345, 5,091, and 2,764 shares, respectively, each paid for in cash on the acquisition date.
RenaissanceRe Holdings Ltd. filed a current report stating that it has released its financial results for the fourth quarter and full year ended December 31, 2025. The company issued a press release and a detailed financial supplement describing these results.
The press release is furnished as Exhibit 99.1 and the financial supplement as Exhibit 99.2 under Item 2.02, meaning they are provided to the SEC but not treated as formally filed or incorporated into other SEC reports. The filing is signed by Executive Vice President and Chief Financial Officer Robert Qutub.
RenaissanceRe Holdings Ltd. entered into an amendment to its secured letter of credit facility with Citibank Europe Plc and several subsidiaries. The change extends the facility’s Availability End Date to December 31, 2026 and its Expiry Date to December 31, 2027, while leaving all other terms unchanged. The facility allows Citibank Europe to issue letters of credit for the participating RenaissanceRe companies in an aggregate amount of up to $320 million, with the ability, subject to conditions, to increase the size of the facility to $350 million. These letters of credit support the companies’ obligations without altering existing financial covenants or pricing terms in this amendment.
T. Rowe Price Associates, Inc. filed Amendment No. 1 to Schedule 13G reporting a passive stake in RenaissanceRe Holdings Ltd. (RNR).
The firm reported beneficial ownership of 2,871,939 shares of common stock, representing 6.1% of the class as of the event date 09/30/2025. It disclosed sole voting power: 2,782,905 shares and sole dispositive power: 2,871,936 shares, with no shared voting or dispositive power. The certification states the securities were acquired and are held in the ordinary course of business and not to influence control.
RenaissanceRe Holdings Ltd filed a Form 13F reporting institutional holdings. The report discloses 5 holdings entries with a reported aggregate market value of $741,196,258. The filing lists 3 other included managers and was signed by Shannon L. Bender on 11-13-2025.
RenaissanceRe Holdings Ltd (RNR) filed a Form 4 disclosing an administrative tax-withholding event. On 11/01/2025, 653 shares of common stock were withheld (Transaction Code F) at $254.09 per share to cover taxes upon the vesting of restricted shares granted on November 8, 2022. After this transaction, the reporting officer, EVP, Chief Underwriting Officer, beneficially owns 89,070 shares, held directly.